SCHEMBL358879

SCHEMBL358879

CCCCCCCCCCCCc1ccc(CO)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.69
ADRA2A P08913 2/20 0.69
ADORA3 P0DMS8 2/20 0.69
TACR2 P21452 2/20 0.69
SLC6A2 P23975 2/20 0.69
SLC6A4 P31645 2/20 0.69
SLC6A3 Q01959 2/20 0.69
ALDH1A1 P00352 2/20 0.69
KDM4E B2RXH2 1/20 0.69
LMNA P02545 1/20 0.69
SHBG P04278 1/20 0.69
TP53 P04637 1/20 0.69
CYP3A4 P08684 1/20 0.69
HSPD1 P10809 1/20 0.69
ADRB3 P13945 1/20 0.69
HTR2C P28335 1/20 0.69
HSPE1 P61604 1/20 0.69
HIF1A Q16665 1/20 0.69
TST Q16762 1/20 0.69
HSD17B10 Q99714 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7769065 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL359311 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL359592 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL176980 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL4297552 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL359570 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL9600021 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL11031408 1.00 ESR1 (0.69) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL357024 0.98 ESR1 (0.65) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL24672063 0.94 RARB (0.64) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4613622-A Sebosuppressive preparations containing benzyl alcohol derivatives HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1986-09-23 US claimed
CN-111689995-B High-solubility triaryl carbon borate and preparation method and application thereof 万华化学集团股份有限公司 2023-09-19 CN disclosed
US-20230231130-A1 POSITIVE ELECTRODE SLURRY COMPOSITION, POSITIVE ELECTRODE PLATE COMPRISING SAME, SECONDARY BATTERY, BATTERY MODULE, BATTERY PACK AND POWER CONSUMING DEVICE CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2023-07-20 US disclosed
US-20230118672-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2023-04-20 US disclosed
CN-114478605-A Highly soluble and highly steric-hindrance trinuclear borate, preparation method thereof, catalyst system and olefin polymerization method 万华化学集团股份有限公司 2022-05-13 CN disclosed
CN-111689995-A High-solubility triaryl carbon borate and preparation method and application thereof 万华化学集团股份有限公司 2020-09-22 CN disclosed
EP-3642260-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC Global Technologies B.V. (NL) 2020-04-29 EP disclosed
CN-110741031-A Substituted poly (alkylene oxide) and surfactant compositions 沙特基础工业全球技术有限公司 2020-01-31 CN disclosed
WO-2018234992-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2018-12-27 WO disclosed
US-9862736-B2 Bimetallic complex comprising cyclopentadienyl and amidine ligands ARLANXEO NETHERLANDS B.V. (NL) 2018-01-09 US disclosed
WO-2001061332-A1 REACTION AND SEPARATION METHODS UNIVERSITY OF PITTSBURGH (US) 2001-08-23 WO disclosed
EP-1061065-A2 Methods for producing cyclopropane carboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-12-20 EP disclosed
US-6090961-A Method for producing titanium complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-07-18 US disclosed
EP-0992479-A1 Method for producing cyclopropanecarboxylates SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-04-12 EP disclosed
EP-0970964-A2 Method for producing titanium complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-01-12 EP disclosed
EP-0141143-B1 SEBOSUPPRESSIVE COSMETIC COMPOSITIONS CONTAINING BENZYL ALCOHOL DERIVATIVES Henkel Kommanditgesellschaft auf Aktien (DE) 1990-01-31 EP disclosed
US-4613622-A Sebosuppressive preparations containing benzyl alcohol derivatives HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1986-09-23 US disclosed
EP-0141143-A2 Sebosuppressive cosmetic compositions containing benzyl alcohol derivatives Henkel Kommanditgesellschaft auf Aktien (DE) 1985-05-15 EP disclosed
US-4252565-A Stabilized phthalocyanines CIBA-GEIGY CORPORATION (US) 1981-02-24 US disclosed
US-4104359-A TREATING WITH SALT OF HYDROXYLAMINE AMAX INC. (US) 1978-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230118672-A1 SUBSTITUTED POLY(ALKYLENE OXIDE) AND SURFACTANT COMPOSITION DECR2, DECR1, C9 ESR1 3698/4885ADRA2A 1099/4885ADORA3 2691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.